Suche nachBristol-Myers Squibb Company

Region
Status
Waren und Dienstleistungen

Ihre Suche hat mehr als 1000 Treffer ergeben. Bitte filtern Sie die Ergebnisse, um die Anzahl der Treffer zu reduzieren.

Land
Aktenzeichen
Marke
Klasse(n)
Inhaber
Anmeldung
Eintragung
Schutzende
Status
USPTO
85532371
BALYFORX
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85532346
METZIGA
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85532332
XIGUMET
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85532236
APEXAGARD
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85532226
APEXIGUARD
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85532217
APEXAGUARD
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85532196
AVEMRY
5
Bristol-Myers Squibb Company
02.02.2012
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85530652
AMPLIFY
42
Bristol-Myers Squibb Company
01.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85530636
EXPANSE
42
Bristol-Myers Squibb Company
01.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85530619
EXPANSE
42
Bristol-Myers Squibb Company
01.02.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE

Darum lohnt sich ein kostenfreier TMDB Account

Marken überwachen und schützen

Wenn Sie eine Markenüberwachung eingerichtet haben, erhalten Sie automatisch eine E-Mail über Nachahmer und Trittbrettfahrer. So funktioniert unkomplizierter Markenschutz in Echtzeit.

Marken ganz einfach folgen

Wenn Sie einer Marke folgen, erhalten Sie eine E-Mail bei neuen Anmeldungen, Widersprüchen, Fristen und Verlängerungen u.v.m. – So bleiben Sie auf dem Laufenden was die Entwicklung einer Marke angeht.

Kostenfrei registrieren
USPTO
85525643
ASSET - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
42
Bristol-Myers Squibb Company
26.01.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85525635
ASCERTAIN - IMPACT OF INTRAVENOUS ABATACEPT ON SYNOVITIS, OSTEITIS AND STRUCTURAL DAMAGE IN PATIENTS WITH RHEUMATOID ARTHRITIS AND AN INADEQUATE RESPONSE TO METHOTREXATE: A RANDOMISED CONTROLLED TRIAL
42
Bristol-Myers Squibb Company
26.01.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85525589
DEDICATE DOUBLE-BLIND EVALUATION OF DAPAGLIFLOZIN ON THE INCIDENCE OF CARDIOVASCULAR-ASSOCIATED EVENTS
42
Bristol-Myers Squibb Company
26.01.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85525586
DIONE DAPAGLIFLOZIN INVESTIGATION OF CARDIOVASCULAR OUTCOMES AND EVENTS
42
Bristol-Myers Squibb Company
26.01.2012
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85504669
ONGLYZA
5
Bristol-Myers Squibb Company
28.12.2011
-
-
ABANDONED-FAILURE TO RESPOND OR LATE RESPONSE
USPTO
85499857
SPRING SUPPORT, PATIENT RESOURCES, INFORMATION AND GUIDANCE
3544
Bristol-Myers Squibb Company
20.12.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85495086
E - ALL OF THE ABOVE
1644
Bristol-Myers Squibb Company
14.12.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85488361
IT'S ABOUT THEIR ODDS
164144
Bristol-Myers Squibb Company
06.12.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85471669
MELANOMA EXPOSED
1644
Bristol-Myers Squibb Company
14.11.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85465639
POSITIVE CHARGE
44
Bristol-Myers Squibb Company
07.11.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85464398
POSI+IVE CHARGE
44
Bristol-Myers Squibb Company
04.11.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85462365
PARTNERS IN DIABETES
42
Bristol-Myers Squibb Company
02.11.2011
22.05.2012
-
CANCELLED - SECTION 8
USPTO
85452050
PROTECTION FOR YOUR KIDNEY TRANSPLANT MATTERS
1641
Bristol-Myers Squibb Company
20.10.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85439799
AVENUE: AN INVESTIGATION AND UNDERSTANDING
42
Bristol-Myers Squibb Company
05.10.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85434249
CHANGE THEIR ODDS
164144
Bristol-Myers Squibb Company
28.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85434235
MAKING A DISTINCT IMPRESSION
164144
Bristol-Myers Squibb Company
28.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85432708
IXEMPRA INVOLVE ME
1641
Bristol-Myers Squibb Company
27.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85427807
MEPLICITI
5
Bristol-Myers Squibb Company
21.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85416397
APLICITI
5
Bristol-Myers Squibb Company
07.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85416388
MEPLICIT
5
Bristol-Myers Squibb Company
07.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85412921
HALLMARK-DAA
42
Bristol-Myers Squibb Company
01.09.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85412909
HALLMARK-QUAD
42
Bristol-Myers Squibb Company
01.09.2011
05.11.2013
-
CANCELLED - SECTION 8
USPTO
85407135
CUSTOMERS @ CENTER
16354144
Bristol-Myers Squibb Company
25.08.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85397766
FIND A STUDY
42
Bristol-Myers Squibb Company
15.08.2011
02.04.2013
-
CANCELLED - SECTION 8
USPTO
85382237
ADVERT: ABATACEPT COMBINED WITH METHOTREXATE IN INDUCING CLINICAL REMISSION IN VERY EARLY RA TRIAL
42
Bristol-Myers Squibb Company
27.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85380946
MOST: THE MELANOMA OBSERVATIONAL STUDY
42
Bristol-Myers Squibb Company
26.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85380942
IMAGE: IPILIMUMAB IN THE MANAGEMENT OF ADVANCED MELANOMA IN ACTUAL PRACTICE
42
Bristol-Myers Squibb Company
26.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85376035
ELOQUENT
42
Bristol-Myers Squibb Company
20.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85376030
TANGELO
42
Bristol-Myers Squibb Company
20.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED
USPTO
85376024
ANTELOPE
42
Bristol-Myers Squibb Company
20.07.2011
-
-
ABANDONED - NO STATEMENT OF USE FILED

Suchergebnisse 761 - 801 von 1000+

Wir lieben Marken.
Und betreuen Sie gerne.

Sie erreichen uns von Montag bis Freitag zwischen 08:00–16:00 Uhr.

Kontaktieren Sie uns.

Wir verwenden Cookies, um Ihre Einstellungen und Statistiken zu speichern und unseren Inhalt zu verbessern. Durch Klicken auf "Alle akzeptieren" akzeptieren Sie die Verwendung von Cookies.

Akzeptieren